CSL Must Face Shire's Willful Infringement Claim
CSL Behring LLC launched its genetic disorder treatment Haegarda despite knowing it could infringe one of Shire ViroPharma Inc.'s patents, so it must face claims that it willfully infringed that patent,...To view the full article, register now.
Already a subscriber? Click here to view full article